ME00030B - GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA - Google Patents
GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJAInfo
- Publication number
- ME00030B ME00030B MEP-2008-19A MEP200819A ME00030B ME 00030 B ME00030 B ME 00030B ME P200819 A MEP200819 A ME P200819A ME 00030 B ME00030 B ME 00030B
- Authority
- ME
- Montenegro
- Prior art keywords
- gaboxadol
- affective disorders
- treating depression
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sadašnji pronalazak se odnosi na upotrebu gaboksadola za pripremanje farmaceutskog sastava za lečenje depresije. šta više, on se odnosi na upotrebu gaboksadola za pripremanje farmaceutskog sastava koji se ima upotrebiti u kombinaciji sa inhibitorom resorbcije serotonina ili bilo kojim jedinjenjem koje izaziva podizanje nivoa ekstracelularnog serotonina.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48301903P | 2003-06-25 | 2003-06-25 | |
DKPA200300956 | 2003-06-25 | ||
US53512304P | 2004-01-07 | 2004-01-07 | |
DKPA200400016 | 2004-01-07 | ||
PCT/DK2004/000459 WO2004112786A2 (en) | 2003-06-25 | 2004-06-25 | Gaboxadol for treating depression and other affective disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ME00030B true ME00030B (me) | 2010-06-10 |
Family
ID=58707228
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-19/08A MEP1908A (xx) | 2003-06-25 | 2004-06-25 | Gabaksadol za liječenje depresije i drugih afektivnih poremećaja |
MEP-2008-19A ME00030B (me) | 2003-06-25 | 2004-06-25 | GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-19/08A MEP1908A (xx) | 2003-06-25 | 2004-06-25 | Gabaksadol za liječenje depresije i drugih afektivnih poremećaja |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20060025192A (me) |
AR (1) | AR047550A1 (me) |
CA (2) | CA2529805A1 (me) |
CL (2) | CL2004001607A1 (me) |
EA (1) | EA200600101A1 (me) |
IS (1) | IS8138A (me) |
ME (2) | MEP1908A (me) |
NO (1) | NO20060229L (me) |
RS (1) | RS20050911A (me) |
TW (1) | TW200509918A (me) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123332B2 (en) | 2018-11-21 | 2021-09-21 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
US11597726B2 (en) | 2020-05-20 | 2023-03-07 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
-
2004
- 2004-06-15 TW TW093117156A patent/TW200509918A/zh unknown
- 2004-06-23 AR ARP040102200A patent/AR047550A1/es not_active Application Discontinuation
- 2004-06-24 CL CL200401607A patent/CL2004001607A1/es unknown
- 2004-06-25 RS YUP-2005/0911A patent/RS20050911A/sr unknown
- 2004-06-25 EA EA200600101A patent/EA200600101A1/ru unknown
- 2004-06-25 ME MEP-19/08A patent/MEP1908A/xx unknown
- 2004-06-25 CA CA002529805A patent/CA2529805A1/en not_active Abandoned
- 2004-06-25 ME MEP-2008-19A patent/ME00030B/me unknown
- 2004-06-25 CA CA2692334A patent/CA2692334A1/en not_active Abandoned
- 2004-06-25 KR KR1020057024823A patent/KR20060025192A/ko not_active Application Discontinuation
-
2005
- 2005-11-21 IS IS8138A patent/IS8138A/is unknown
-
2006
- 2006-01-16 NO NO20060229A patent/NO20060229L/no not_active Application Discontinuation
-
2010
- 2010-02-25 CL CL2010000166A patent/CL2010000166A1/es unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123332B2 (en) | 2018-11-21 | 2021-09-21 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
US11597726B2 (en) | 2020-05-20 | 2023-03-07 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
Also Published As
Publication number | Publication date |
---|---|
EA200600101A1 (ru) | 2006-06-30 |
KR20060025192A (ko) | 2006-03-20 |
CA2529805A1 (en) | 2004-12-29 |
MEP1908A (xx) | 2010-02-10 |
CL2010000166A1 (es) | 2010-07-02 |
IS8138A (is) | 2005-11-21 |
RS20050911A (en) | 2007-08-03 |
TW200509918A (en) | 2005-03-16 |
AR047550A1 (es) | 2006-01-25 |
CA2692334A1 (en) | 2004-12-29 |
NO20060229L (no) | 2006-01-16 |
CL2004001607A1 (es) | 2005-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120961T1 (el) | Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος | |
CY1110046T1 (el) | Γαβοξαδολη για τη θεραπεια της καταθλιψης και αλλων συναισθηματικων διαταραχων | |
PA8596901A1 (es) | Inhibidores de p38 y metodos de uso de ellos | |
DK1556021T3 (da) | Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger | |
DE60117605D1 (de) | Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie | |
EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
ATE554114T1 (de) | Copolymer mit zwitterionischen einheiten und anderen einheiten, das copolymer umfassende zusammensetzung und verwendung | |
NO20073254L (no) | Sammensetninger omfattende ornitin og fenylacetat eller fenylbutyrat for a behandle hepatisk encefalopati | |
ECSP077401A (es) | Medicamentos que contienen compuestos de carbonilo y su uso | |
CY1112238T1 (el) | Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων | |
CY1109985T1 (el) | Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων | |
EA200701820A1 (ru) | Применение диосметиновых соединений при лечении и профилактике тромботических патологий | |
BRPI0412265A (pt) | uso de calcitonina em osteoartrite | |
ATE409065T1 (de) | Inhibitoren der 17 beta- hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten | |
NO20065859L (no) | Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser | |
NO20093542L (no) | Inhibering av tumormetastase ved hjelp av anti-neuropilin 2-antistoffer | |
DE602005009681D1 (de) | Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle | |
HRP20050579B1 (hr) | Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol | |
RS54185B1 (en) | USE OF 24-ORDER | |
DK1575590T3 (da) | Carbostyrilderivater og serotoningenoptagelsesinhibitorer til behandling af sindsstemningslidelser | |
CL2008003602A1 (es) | Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos. | |
ATE506954T1 (de) | Adjuvans mit einem oligonukleotid und nicht- toxischem lps | |
AR039664A1 (es) | Composicion farmaceutica que comprende un inhibidor de lipasa y glucomanan | |
RS51534B (en) | NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT | |
ME00030B (me) | GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA |